Zami Aberman
Overview
Zami Aberman received an average of $2M in total compensation, including $452K in salary, at Pluristem Therapeutics from 2008 to 2022.
2022Pluristem TherapeuticsChairman
2021Pluristem TherapeuticsChairman
2020Pluristem TherapeuticsExecutive Chairman
2019Pluristem TherapeuticsExecutive Chairman
2018Pluristem TherapeuticsCo, CEO
2017Pluristem TherapeuticsCo, CEO
2016Pluristem TherapeuticsCo, CEO
2015Pluristem TherapeuticsCo, CEO
2014Pluristem TherapeuticsCo, CEO
2013Pluristem TherapeuticsChief Executive Officer
Source: SEC filings on February 27, 2023, April 8, 2021, May 20, 2020, April 25, 2019, April 3, 2018, March 30, 2017, March 31, 2014, March 29, 2013, March 22, 2012, April 15, 2011, and November 23, 2009.
Related executives
We found three more executives who work or worked at Pluristem Therapeutics.
News
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019